COVID-19 Impact on Global Orthopedic Oncology Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 96 pages | ID: C2D869FD1AB8EN
QYResearch

Abstracts

This report focuses on the global Orthopedic Oncology Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orthopedic Oncology Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• DePuy Synthes (Johnson & Johnson)
• Medtronic
• Accentus Medical
• Roche Holding AG
• Amgen, Inc.
• Novartis AG
• GlaxoSmithKline
• Sanofi
• Pfizer Inc.

Market segment by Type, the product can be split into

• Soft Tissue Excisions/Resections
• Limb Salvage Surgery
• Amputation
• Adjuvant Chemotherapy
• Reconstructive Surgery

Market segment by Application, split into

• Hospitals
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Orthopedic Oncology Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Orthopedic Oncology Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Orthopedic Oncology Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Orthopedic Oncology Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Orthopedic Oncology Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Soft Tissue Excisions/Resections
  1.4.3 Limb Salvage Surgery
  1.4.4 Amputation
  1.4.5 Adjuvant Chemotherapy
  1.4.6 Reconstructive Surgery
1.5 Market by Application
  1.5.1 Global Orthopedic Oncology Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Orthopedic Oncology Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Orthopedic Oncology Treatment Industry
    1.6.1.1 Orthopedic Oncology Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Orthopedic Oncology Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Orthopedic Oncology Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Orthopedic Oncology Treatment Market Perspective (2015-2026)
2.2 Orthopedic Oncology Treatment Growth Trends by Regions
  2.2.1 Orthopedic Oncology Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Orthopedic Oncology Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Orthopedic Oncology Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Orthopedic Oncology Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Orthopedic Oncology Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Orthopedic Oncology Treatment Players by Market Size
  3.1.1 Global Top Orthopedic Oncology Treatment Players by Revenue (2015-2020)
  3.1.2 Global Orthopedic Oncology Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Orthopedic Oncology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Orthopedic Oncology Treatment Market Concentration Ratio
  3.2.1 Global Orthopedic Oncology Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Orthopedic Oncology Treatment Revenue in 2019
3.3 Orthopedic Oncology Treatment Key Players Head office and Area Served
3.4 Key Players Orthopedic Oncology Treatment Product Solution and Service
3.5 Date of Enter into Orthopedic Oncology Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Orthopedic Oncology Treatment Historic Market Size by Type (2015-2020)
4.2 Global Orthopedic Oncology Treatment Forecasted Market Size by Type (2021-2026)

5 ORTHOPEDIC ONCOLOGY TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Orthopedic Oncology Treatment Market Size by Application (2015-2020)
5.2 Global Orthopedic Oncology Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Orthopedic Oncology Treatment Market Size (2015-2020)
6.2 Orthopedic Oncology Treatment Key Players in North America (2019-2020)
6.3 North America Orthopedic Oncology Treatment Market Size by Type (2015-2020)
6.4 North America Orthopedic Oncology Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Orthopedic Oncology Treatment Market Size (2015-2020)
7.2 Orthopedic Oncology Treatment Key Players in Europe (2019-2020)
7.3 Europe Orthopedic Oncology Treatment Market Size by Type (2015-2020)
7.4 Europe Orthopedic Oncology Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Orthopedic Oncology Treatment Market Size (2015-2020)
8.2 Orthopedic Oncology Treatment Key Players in China (2019-2020)
8.3 China Orthopedic Oncology Treatment Market Size by Type (2015-2020)
8.4 China Orthopedic Oncology Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Orthopedic Oncology Treatment Market Size (2015-2020)
9.2 Orthopedic Oncology Treatment Key Players in Japan (2019-2020)
9.3 Japan Orthopedic Oncology Treatment Market Size by Type (2015-2020)
9.4 Japan Orthopedic Oncology Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Orthopedic Oncology Treatment Market Size (2015-2020)
10.2 Orthopedic Oncology Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Orthopedic Oncology Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Orthopedic Oncology Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Orthopedic Oncology Treatment Market Size (2015-2020)
11.2 Orthopedic Oncology Treatment Key Players in India (2019-2020)
11.3 India Orthopedic Oncology Treatment Market Size by Type (2015-2020)
11.4 India Orthopedic Oncology Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Orthopedic Oncology Treatment Market Size (2015-2020)
12.2 Orthopedic Oncology Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Orthopedic Oncology Treatment Market Size by Type (2015-2020)
12.4 Central & South America Orthopedic Oncology Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Stryker Corporation
  13.1.1 Stryker Corporation Company Details
  13.1.2 Stryker Corporation Business Overview and Its Total Revenue
  13.1.3 Stryker Corporation Orthopedic Oncology Treatment Introduction
  13.1.4 Stryker Corporation Revenue in Orthopedic Oncology Treatment Business (2015-2020))
  13.1.5 Stryker Corporation Recent Development
13.2 Zimmer Biomet Holdings, Inc.
  13.2.1 Zimmer Biomet Holdings, Inc. Company Details
  13.2.2 Zimmer Biomet Holdings, Inc. Business Overview and Its Total Revenue
  13.2.3 Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Introduction
  13.2.4 Zimmer Biomet Holdings, Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020)
  13.2.5 Zimmer Biomet Holdings, Inc. Recent Development
13.3 Smith & Nephew plc
  13.3.1 Smith & Nephew plc Company Details
  13.3.2 Smith & Nephew plc Business Overview and Its Total Revenue
  13.3.3 Smith & Nephew plc Orthopedic Oncology Treatment Introduction
  13.3.4 Smith & Nephew plc Revenue in Orthopedic Oncology Treatment Business (2015-2020)
  13.3.5 Smith & Nephew plc Recent Development
13.4 DePuy Synthes (Johnson & Johnson)
  13.4.1 DePuy Synthes (Johnson & Johnson) Company Details
  13.4.2 DePuy Synthes (Johnson & Johnson) Business Overview and Its Total Revenue
  13.4.3 DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Introduction
  13.4.4 DePuy Synthes (Johnson & Johnson) Revenue in Orthopedic Oncology Treatment Business (2015-2020)
  13.4.5 DePuy Synthes (Johnson & Johnson) Recent Development
13.5 Medtronic
  13.5.1 Medtronic Company Details
  13.5.2 Medtronic Business Overview and Its Total Revenue
  13.5.3 Medtronic Orthopedic Oncology Treatment Introduction
  13.5.4 Medtronic Revenue in Orthopedic Oncology Treatment Business (2015-2020)
  13.5.5 Medtronic Recent Development
13.6 Accentus Medical
  13.6.1 Accentus Medical Company Details
  13.6.2 Accentus Medical Business Overview and Its Total Revenue
  13.6.3 Accentus Medical Orthopedic Oncology Treatment Introduction
  13.6.4 Accentus Medical Revenue in Orthopedic Oncology Treatment Business (2015-2020)
  13.6.5 Accentus Medical Recent Development
13.7 Roche Holding AG
  13.7.1 Roche Holding AG Company Details
  13.7.2 Roche Holding AG Business Overview and Its Total Revenue
  13.7.3 Roche Holding AG Orthopedic Oncology Treatment Introduction
  13.7.4 Roche Holding AG Revenue in Orthopedic Oncology Treatment Business (2015-2020)
  13.7.5 Roche Holding AG Recent Development
13.8 Amgen, Inc.
  13.8.1 Amgen, Inc. Company Details
  13.8.2 Amgen, Inc. Business Overview and Its Total Revenue
  13.8.3 Amgen, Inc. Orthopedic Oncology Treatment Introduction
  13.8.4 Amgen, Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020)
  13.8.5 Amgen, Inc. Recent Development
13.9 Novartis AG
  13.9.1 Novartis AG Company Details
  13.9.2 Novartis AG Business Overview and Its Total Revenue
  13.9.3 Novartis AG Orthopedic Oncology Treatment Introduction
  13.9.4 Novartis AG Revenue in Orthopedic Oncology Treatment Business (2015-2020)
  13.9.5 Novartis AG Recent Development
13.10 GlaxoSmithKline
  13.10.1 GlaxoSmithKline Company Details
  13.10.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.10.3 GlaxoSmithKline Orthopedic Oncology Treatment Introduction
  13.10.4 GlaxoSmithKline Revenue in Orthopedic Oncology Treatment Business (2015-2020)
  13.10.5 GlaxoSmithKline Recent Development
13.11 Sanofi
  10.11.1 Sanofi Company Details
  10.11.2 Sanofi Business Overview and Its Total Revenue
  10.11.3 Sanofi Orthopedic Oncology Treatment Introduction
  10.11.4 Sanofi Revenue in Orthopedic Oncology Treatment Business (2015-2020)
  10.11.5 Sanofi Recent Development
13.12 Pfizer Inc.
  10.12.1 Pfizer Inc. Company Details
  10.12.2 Pfizer Inc. Business Overview and Its Total Revenue
  10.12.3 Pfizer Inc. Orthopedic Oncology Treatment Introduction
  10.12.4 Pfizer Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020)
  10.12.5 Pfizer Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Orthopedic Oncology Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Orthopedic Oncology Treatment Revenue
Table 3. Ranking of Global Top Orthopedic Oncology Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Orthopedic Oncology Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Soft Tissue Excisions/Resections
Table 6. Key Players of Limb Salvage Surgery
Table 7. Key Players of Amputation
Table 8. Key Players of Adjuvant Chemotherapy
Table 9. Key Players of Reconstructive Surgery
Table 10. COVID-19 Impact Global Market: (Four Orthopedic Oncology Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Orthopedic Oncology Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Orthopedic Oncology Treatment Players to Combat Covid-19 Impact
Table 15. Global Orthopedic Oncology Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Orthopedic Oncology Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Orthopedic Oncology Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Orthopedic Oncology Treatment Market Share by Regions (2015-2020)
Table 19. Global Orthopedic Oncology Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Orthopedic Oncology Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Orthopedic Oncology Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Orthopedic Oncology Treatment Players
Table 26. Global Orthopedic Oncology Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Orthopedic Oncology Treatment Market Share by Players (2015-2020)
Table 28. Global Top Orthopedic Oncology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orthopedic Oncology Treatment as of 2019)
Table 29. Global Orthopedic Oncology Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Orthopedic Oncology Treatment Product Solution and Service
Table 32. Date of Enter into Orthopedic Oncology Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Orthopedic Oncology Treatment Market Size Share by Type (2015-2020)
Table 36. Global Orthopedic Oncology Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Orthopedic Oncology Treatment Market Size Share by Application (2015-2020)
Table 38. Global Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Orthopedic Oncology Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Orthopedic Oncology Treatment Market Share (2019-2020)
Table 42. North America Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Orthopedic Oncology Treatment Market Share by Type (2015-2020)
Table 44. North America Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Orthopedic Oncology Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Orthopedic Oncology Treatment Market Share (2019-2020)
Table 48. Europe Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Orthopedic Oncology Treatment Market Share by Type (2015-2020)
Table 50. Europe Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Orthopedic Oncology Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Orthopedic Oncology Treatment Market Share (2019-2020)
Table 54. China Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Orthopedic Oncology Treatment Market Share by Type (2015-2020)
Table 56. China Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Orthopedic Oncology Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Orthopedic Oncology Treatment Market Share (2019-2020)
Table 60. Japan Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Orthopedic Oncology Treatment Market Share by Type (2015-2020)
Table 62. Japan Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Orthopedic Oncology Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Orthopedic Oncology Treatment Market Share (2019-2020)
Table 66. Southeast Asia Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Orthopedic Oncology Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Orthopedic Oncology Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Orthopedic Oncology Treatment Market Share (2019-2020)
Table 72. India Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Orthopedic Oncology Treatment Market Share by Type (2015-2020)
Table 74. India Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Orthopedic Oncology Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Orthopedic Oncology Treatment Market Share (2019-2020)
Table 78. Central & South America Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Orthopedic Oncology Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Orthopedic Oncology Treatment Market Share by Application (2015-2020)
Table 82. Stryker Corporation Company Details
Table 83. Stryker Corporation Business Overview
Table 84. Stryker Corporation Product
Table 85. Stryker Corporation Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 86. Stryker Corporation Recent Development
Table 87. Zimmer Biomet Holdings, Inc. Company Details
Table 88. Zimmer Biomet Holdings, Inc. Business Overview
Table 89. Zimmer Biomet Holdings, Inc. Product
Table 90. Zimmer Biomet Holdings, Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 91. Zimmer Biomet Holdings, Inc. Recent Development
Table 92. Smith & Nephew plc Company Details
Table 93. Smith & Nephew plc Business Overview
Table 94. Smith & Nephew plc Product
Table 95. Smith & Nephew plc Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 96. Smith & Nephew plc Recent Development
Table 97. DePuy Synthes (Johnson & Johnson) Company Details
Table 98. DePuy Synthes (Johnson & Johnson) Business Overview
Table 99. DePuy Synthes (Johnson & Johnson) Product
Table 100. DePuy Synthes (Johnson & Johnson) Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 101. DePuy Synthes (Johnson & Johnson) Recent Development
Table 102. Medtronic Company Details
Table 103. Medtronic Business Overview
Table 104. Medtronic Product
Table 105. Medtronic Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 106. Medtronic Recent Development
Table 107. Accentus Medical Company Details
Table 108. Accentus Medical Business Overview
Table 109. Accentus Medical Product
Table 110. Accentus Medical Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 111. Accentus Medical Recent Development
Table 112. Roche Holding AG Company Details
Table 113. Roche Holding AG Business Overview
Table 114. Roche Holding AG Product
Table 115. Roche Holding AG Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 116. Roche Holding AG Recent Development
Table 117. Amgen, Inc. Business Overview
Table 118. Amgen, Inc. Product
Table 119. Amgen, Inc. Company Details
Table 120. Amgen, Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 121. Amgen, Inc. Recent Development
Table 122. Novartis AG Company Details
Table 123. Novartis AG Business Overview
Table 124. Novartis AG Product
Table 125. Novartis AG Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 126. Novartis AG Recent Development
Table 127. GlaxoSmithKline Company Details
Table 128. GlaxoSmithKline Business Overview
Table 129. GlaxoSmithKline Product
Table 130. GlaxoSmithKline Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 131. GlaxoSmithKline Recent Development
Table 132. Sanofi Company Details
Table 133. Sanofi Business Overview
Table 134. Sanofi Product
Table 135. Sanofi Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 136. Sanofi Recent Development
Table 137. Pfizer Inc. Company Details
Table 138. Pfizer Inc. Business Overview
Table 139. Pfizer Inc. Product
Table 140. Pfizer Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)
Table 141. Pfizer Inc. Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Orthopedic Oncology Treatment Market Share by Type: 2020 VS 2026
Figure 2. Soft Tissue Excisions/Resections Features
Figure 3. Limb Salvage Surgery Features
Figure 4. Amputation Features
Figure 5. Adjuvant Chemotherapy Features
Figure 6. Reconstructive Surgery Features
Figure 7. Global Orthopedic Oncology Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Orthopedic Oncology Treatment Report Years Considered
Figure 12. Global Orthopedic Oncology Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Orthopedic Oncology Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Orthopedic Oncology Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Orthopedic Oncology Treatment Market Share by Players in 2019
Figure 17. Global Top Orthopedic Oncology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orthopedic Oncology Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Orthopedic Oncology Treatment Revenue in 2019
Figure 19. North America Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Stryker Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Stryker Corporation Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 28. Zimmer Biomet Holdings, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Zimmer Biomet Holdings, Inc. Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 30. Smith & Nephew plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Smith & Nephew plc Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 32. DePuy Synthes (Johnson & Johnson) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. DePuy Synthes (Johnson & Johnson) Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 34. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Medtronic Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 36. Accentus Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Accentus Medical Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 38. Roche Holding AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Roche Holding AG Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 40. Amgen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Amgen, Inc. Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 42. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Novartis AG Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 44. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. GlaxoSmithKline Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 46. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Sanofi Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 48. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Pfizer Inc. Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed